Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACXP Acurx Pharmaceuticals, LLC*

盘后交易 11-22 19:25:21 EST

1.35

+0.05

+3.85%

盘后1.37

+0.02+1.47%

19:08 EST

最高1.43	最低1.30	成交量18.31万
今开1.35	昨收1.30	日振幅10.00%
总市值2,193万	流通市值1,868万	总股本1,625万
成交额24.72万	换手率1.32%	流通股本1,384万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACXP","market":"US","secType":"STK","nameCN":"Acurx Pharmaceuticals, LLC*","latestPrice":1.35,"timestamp":1732309200000,"preClose":1.3,"halted":0,"volume":183145,"hourTrading":{"tag":"盘后","latestPrice":1.3699,"preClose":1.35,"latestTime":"19:08 EST","volume":245,"amount":331.8013195,"timestamp":1732320530344},"delay":0,"floatShares":13840476,"shares":16245099,"eps":-1.067897,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.05,"latestTime":"11-22 19:25:21 EST","open":1.35,"high":1.43,"low":1.3,"amount":247203.97462549998,"amplitude":0.1,"askPrice":1.37,"askSize":199,"bidPrice":1.34,"bidSize":340,"shortable":3,"etf":0,"ttmEps":-1.067897,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":0,"listingDate":1624593600000,"adjPreClose":1.3,"preHourTrading":{"tag":"盘前","latestPrice":1.35,"preClose":1.3,"latestTime":"09:29 EST","volume":3125,"amount":4261.32875,"timestamp":1732285799999},"postHourTrading":{"tag":"盘后","latestPrice":1.3699,"preClose":1.35,"latestTime":"19:08 EST","volume":245,"amount":331.8013195,"timestamp":1732320530344},"volumeRatio":0.586291,"impliedVol":1.9653,"impliedVolPercentile":0.8571},"requestUrl":"/m/hq/s/ACXP/wiki","defaultTab":"wiki","newsList":[{"id":"2485989612","title":"Acurx Pharmaceuticals, Inc.2024财年第三财季实现净利润-2.82百万美元，同比增加9.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485989612","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485989612?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:00","pubTimestamp":1732291211,"startTime":"0","endTime":"0","summary":"11月23日，Acurx Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.82百万美元，同比增加9.32%；其中营业收入为0.00美元，每股基本收益为-0.17美元。从资产负债表来看，Acurx Pharmaceuticals, Inc.总负债3.32百万美元，其中短期债务0.00美元，资产负债比为1.81，流动比率为1.81。机构评级：截至2024年11月23日，当前有2家机构对Acurx Pharmaceuticals, Inc.目标价做出预测，其中目标均价为11.00美元，其中最低目标价为10.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000022a24e4805&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000022a24e4805&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP"],"gpt_icon":0},{"id":"2485264721","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大涨5.38%报1.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485264721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485264721?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:48","pubTimestamp":1732286908,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时48分，Acurx Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.38%。截至发稿，该股报1.37美元/股，成交量4.5168万股，换手率0.27%，振幅7.69%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224828abd799e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122224828abd799e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4563","BK4539","VRPX","ACXP","BK4139"],"gpt_icon":0},{"id":"2485550497","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485550497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485550497?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:34","pubTimestamp":1732199643,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时34分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.03%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122340395be4ec8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122340395be4ec8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4563","BK4139","BK4539"],"gpt_icon":0},{"id":"2484148601","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.99%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484148601","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484148601?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:46","pubTimestamp":1732113960,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时46分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.99%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224601a248c943&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120224601a248c943&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4563","ACXP"],"gpt_icon":0},{"id":"2482173961","title":"Acurx Pharmaceuticals Inc 预计每股亏损20美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482173961","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482173961?lang=zh_cn&edition=full","pubTime":"2024-11-11 23:36","pubTimestamp":1731339411,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc 预计每股亏损20美分 - 财报前瞻Acurx Pharmaceuticals Inc ACXP.OQ ACXP.O将于11月13日公布截至2024年9月30日的财报，预计季度收入将保持不变。LSEG分析师对Acurx Pharmaceuticals Inc的平均预期是每股亏损20美分。华尔街对 Acurx Pharmaceuticals Inc 的 12 个月目标价中位数为 11.89 美元，高于上一次收盘价 1.86 美元。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nL4S3MI153:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2460886621","title":"Acurx Pharmaceuticals, Inc.盘中异动 临近午盘急速上涨5.19%报2.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460886621","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460886621?lang=zh_cn&edition=full","pubTime":"2024-08-20 23:34","pubTimestamp":1724168091,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日23时34分，Acurx Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.19%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820233452a1d53e77&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820233452a1d53e77&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4539","ACXP","BK4139"],"gpt_icon":0},{"id":"2460736617","title":"Acurx Pharmaceuticals, Inc.2024财年第二财季实现净利润-4.12百万美元，同比减少19.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460736617","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460736617?lang=zh_cn&edition=full","pubTime":"2024-08-18 00:04","pubTimestamp":1723910676,"startTime":"0","endTime":"0","summary":"8月18日，Acurx Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-4.12百万美元，同比减少19.42%；其中营业收入为0.00美元，每股基本收益为-0.26美元。从资产负债表来看，Acurx Pharmaceuticals, Inc.总负债3.15百万美元，其中短期债务0.00美元，资产负债比为2.09，流动比率为2.09。机构评级：截至2024年8月18日，当前有2家机构对Acurx Pharmaceuticals, Inc.目标价做出预测，其中目标均价为11.00美元，其中最低目标价为10.00美元，最高目标价为12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800071495a16851&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800071495a16851&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP"],"gpt_icon":0},{"id":"2459982474","title":"Acurx Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459982474","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459982474?lang=zh_cn&edition=full","pubTime":"2024-08-15 23:32","pubTimestamp":1723735933,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日23时32分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.20%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815233213a1d47518&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815233213a1d47518&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ACXP","BK4563"],"gpt_icon":0},{"id":"2458595609","title":"Acurx Pharmaceuticals, Inc.股价拉升11.05% 市值涨369.39万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458595609","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458595609?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:31","pubTimestamp":1723210306,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时31分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨11.05%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213146958bfdc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213146958bfdc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","BK4563","ACXP"],"gpt_icon":0},{"id":"2457256058","title":"Acurx Pharmaceuticals Inc   预计每股亏损22美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457256058","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457256058?lang=zh_cn&edition=full","pubTime":"2024-08-07 23:30","pubTimestamp":1723044608,"startTime":"0","endTime":"0","summary":"   * Acurx Pharmaceuticals Inc    将于8月9日公布截至2024年6月30日的财报，预计季度收入将保持不变。*    * LSEG分析师对Acurx Pharmaceuticals Inc的平均预期是每股亏损22美分。* 华尔街对 Acurx Pharmaceuticals Inc 的 12 个月目标价中位数为 11.32 美元，高于其最新收盘价 2.04 美元。8月7日 - 本摘要于北京时间8月7日15:30自动生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Acurx Pharmaceuticals Inc   预计每股亏损22美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACXP"],"gpt_icon":0},{"id":"2455665312","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘快速拉升7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455665312","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455665312?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:35","pubTimestamp":1722260150,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日21时35分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅拉升7.02%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729213551af94a210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729213551af94a210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4563","BK4139","ACXP"],"gpt_icon":0},{"id":"2454328689","title":"Acurx Pharmaceuticals, Inc.盘中异动 股价大涨6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454328689","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454328689?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:55","pubTimestamp":1722002100,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时55分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨6.19%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072621550096820d06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072621550096820d06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ACXP","BK4563"],"gpt_icon":0},{"id":"2454807114","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.86%报2.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454807114","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454807114?lang=zh_cn&edition=full","pubTime":"2024-07-26 01:30","pubTimestamp":1721928605,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日01时30分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.86%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726013005941fab02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726013005941fab02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACXP","BK4539","BK4563"],"gpt_icon":0},{"id":"2453587940","title":"Acurx Pharmaceuticals, Inc.盘中异动 快速拉升5.82%报2.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453587940","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453587940?lang=zh_cn&edition=full","pubTime":"2024-07-23 21:58","pubTimestamp":1721743109,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日21时58分，Acurx Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.82%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232158299681f5a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407232158299681f5a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ACXP","BK4563","BK4139"],"gpt_icon":0},{"id":"2453795146","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453795146","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453795146?lang=zh_cn&edition=full","pubTime":"2024-07-22 22:08","pubTimestamp":1721657300,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日22时08分，Acurx Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.35%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222208209681ee85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407222208209681ee85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0},{"id":"2452771324","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.51%报2.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452771324","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452771324?lang=zh_cn&edition=full","pubTime":"2024-07-19 22:45","pubTimestamp":1721400329,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日22时45分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.51%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719224529aefa8beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719224529aefa8beb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4007","BK4539","BK4139","BK4563","VRPX"],"gpt_icon":0},{"id":"2452482590","title":"Acurx Pharmaceuticals, Inc.股价上涨10.31% 市值涨472.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452482590","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452482590?lang=zh_cn&edition=full","pubTime":"2024-07-18 21:32","pubTimestamp":1721309525,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日21时32分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅上涨10.31%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071821320595d67425&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071821320595d67425&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","ACXP","BK4139","BK4539"],"gpt_icon":0},{"id":"2451990403","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451990403","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451990403?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:36","pubTimestamp":1721137017,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时36分，Acurx Pharmaceuticals, Inc.股票出现异动，股价快速上涨6.30%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213658af929930&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213658af929930&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4563","BK4539","BK4139"],"gpt_icon":0},{"id":"2451628363","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.17%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451628363","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451628363?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:32","pubTimestamp":1721050334,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时32分，Acurx Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.17%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152132149f4f2343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152132149f4f2343&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ACXP","BK4563"],"gpt_icon":0},{"id":"2450534666","title":"Acurx Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.52%报2.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450534666","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450534666?lang=zh_cn&edition=full","pubTime":"2024-07-12 22:37","pubTimestamp":1720795057,"startTime":"0","endTime":"0","summary":"北京时间2024年07月12日22时37分，Acurx Pharmaceuticals, Inc.股票出现异动，股价大幅拉升6.52%。截至发稿，该股报2.45美元/股，成交量2.4372万股，换手率0.15%，振幅2.82%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.75%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712223737941f6ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712223737941f6ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACXP","BK4139","BK4539","BK4563"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acurxpharma.com","stockEarnings":[{"period":"1week","weight":-0.2655},{"period":"1month","weight":-0.3194},{"period":"3month","weight":-0.4273},{"period":"6month","weight":-0.4821},{"period":"1year","weight":-0.6533},{"period":"ytd","weight":-0.6606}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acurx Pharmaceuticals, Inc.于2017年7月在特拉华州注册成立，于2018年2月开始运营。他们是临床阶段的生物制药公司，致力于开发新型抗生素，用于治疗被世界卫生组织列为优先病原体的细菌引起的感染（“WHO”），美国疾病控制与预防中心（“CDC”）和美国食品和药物管理局（“FDA”）。优先病原体是那些需要新抗生素来解决由WHO、CDC和FDA确定的全球抗微生物药物耐药性（“AMR”）危机的病原体。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.093013},{"month":2,"riseRate":0,"avgChangeRate":-0.109365},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.066567},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.033561},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.033707},{"month":6,"riseRate":0.333333,"avgChangeRate":0.053392},{"month":7,"riseRate":0,"avgChangeRate":-0.109772},{"month":8,"riseRate":0.25,"avgChangeRate":-0.036425},{"month":9,"riseRate":0,"avgChangeRate":-0.126336},{"month":10,"riseRate":0.5,"avgChangeRate":0.638893},{"month":11,"riseRate":0.25,"avgChangeRate":-0.163713},{"month":12,"riseRate":0.666667,"avgChangeRate":0.07867}],"exchange":"NASDAQ","name":"Acurx Pharmaceuticals, LLC*","nameEN":"Acurx Pharmaceuticals, LLC*"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acurx Pharmaceuticals, LLC*,ACXP,Acurx Pharmaceuticals, LLC*股票,Acurx Pharmaceuticals, LLC*股票老虎,Acurx Pharmaceuticals, LLC*股票老虎国际,Acurx Pharmaceuticals, LLC*行情,Acurx Pharmaceuticals, LLC*股票行情,Acurx Pharmaceuticals, LLC*股价,Acurx Pharmaceuticals, LLC*股市,Acurx Pharmaceuticals, LLC*股票价格,Acurx Pharmaceuticals, LLC*股票交易,Acurx Pharmaceuticals, LLC*股票购买,Acurx Pharmaceuticals, LLC*股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acurx Pharmaceuticals, LLC*(ACXP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acurx Pharmaceuticals, LLC*(ACXP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}